Skip to main content
Journal cover image

Trends, Predictors, and Outcomes of Bleeding Complications After Mitral Transcatheter Edge-to-Edge Repair: TVT Registry Insights.

Publication ,  Journal Article
Singh, N; Cohen, DJ; Shah, MA; Kosinski, AS; Brothers, L; Vemulapalli, S; Elmariah, S
Published in: JACC Cardiovasc Interv
October 28, 2024

BACKGROUND: Bleeding events after arterial transcatheter procedures are associated with increased morbidity and mortality. The frequency and clinical implications of bleeding after mitral transcatheter edge-to-edge repair (M-TEER) have not been well-studied. OBJECTIVES: The authors sought to explore the association of in-hospital bleeding events after M-TEER with patient outcomes. METHODS: Patients undergoing M-TEER who were included in the TVT (Transcatheter Valve Therapy) Registry between 2013 and 2022 were included. Rates of the primary endpoint, the composite of death or hospital readmission at 30 days, were compared between patients who experienced in-hospital major or life-threatening bleeding vs those without bleeding. Secondary analyses examined the association between in-hospital bleeding and death or readmission at 1 year, as well as independent predictors of major in-hospital bleeding. RESULTS: Over the study period, in-hospital major bleeding occurred in 1,205 (2.3%) of 51,533 patients. Rates of bleeding decreased over time (from 7.1% in 2013 to 2.0% in 2021; P < 0.001). In-hospital bleeding was associated with increased rates of death or readmission at both 30 days (adjusted OR: 2.15 [95% CI: 1.81-2.54]; P < 0.0001) and 1 year (adjusted HR: 1.43 [95% CI: 1.27-1.60]; P < 0.0001). The strongest correlates of in-hospital bleeding included female sex, prior percutaneous coronary intervention, baseline hemoglobin, greater procedure acuity, and longer procedure duration. CONCLUSIONS: Bleeding after M-TEER is associated with increased risk of subsequent death and hospital readmission. Although reductions in bleeding complications over time are encouraging, continued efforts are needed to further mitigate hemorrhagic complications of M-TEER.

Duke Scholars

Published In

JACC Cardiovasc Interv

DOI

EISSN

1876-7605

Publication Date

October 28, 2024

Volume

17

Issue

20

Start / End Page

2337 / 2349

Location

United States

Related Subject Headings

  • United States
  • Treatment Outcome
  • Time Factors
  • Risk Factors
  • Risk Assessment
  • Registries
  • Postoperative Hemorrhage
  • Patient Readmission
  • Mitral Valve Insufficiency
  • Mitral Valve
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Singh, N., Cohen, D. J., Shah, M. A., Kosinski, A. S., Brothers, L., Vemulapalli, S., & Elmariah, S. (2024). Trends, Predictors, and Outcomes of Bleeding Complications After Mitral Transcatheter Edge-to-Edge Repair: TVT Registry Insights. JACC Cardiovasc Interv, 17(20), 2337–2349. https://doi.org/10.1016/j.jcin.2024.09.035
Singh, Nickpreet, David J. Cohen, Miloni A. Shah, Andrzej S. Kosinski, Leo Brothers, Sreekanth Vemulapalli, and Sammy Elmariah. “Trends, Predictors, and Outcomes of Bleeding Complications After Mitral Transcatheter Edge-to-Edge Repair: TVT Registry Insights.JACC Cardiovasc Interv 17, no. 20 (October 28, 2024): 2337–49. https://doi.org/10.1016/j.jcin.2024.09.035.
Singh N, Cohen DJ, Shah MA, Kosinski AS, Brothers L, Vemulapalli S, et al. Trends, Predictors, and Outcomes of Bleeding Complications After Mitral Transcatheter Edge-to-Edge Repair: TVT Registry Insights. JACC Cardiovasc Interv. 2024 Oct 28;17(20):2337–49.
Singh, Nickpreet, et al. “Trends, Predictors, and Outcomes of Bleeding Complications After Mitral Transcatheter Edge-to-Edge Repair: TVT Registry Insights.JACC Cardiovasc Interv, vol. 17, no. 20, Oct. 2024, pp. 2337–49. Pubmed, doi:10.1016/j.jcin.2024.09.035.
Singh N, Cohen DJ, Shah MA, Kosinski AS, Brothers L, Vemulapalli S, Elmariah S. Trends, Predictors, and Outcomes of Bleeding Complications After Mitral Transcatheter Edge-to-Edge Repair: TVT Registry Insights. JACC Cardiovasc Interv. 2024 Oct 28;17(20):2337–2349.
Journal cover image

Published In

JACC Cardiovasc Interv

DOI

EISSN

1876-7605

Publication Date

October 28, 2024

Volume

17

Issue

20

Start / End Page

2337 / 2349

Location

United States

Related Subject Headings

  • United States
  • Treatment Outcome
  • Time Factors
  • Risk Factors
  • Risk Assessment
  • Registries
  • Postoperative Hemorrhage
  • Patient Readmission
  • Mitral Valve Insufficiency
  • Mitral Valve